Sulcal morphology as a new imaging marker for the diagnosis of early onset Alzheimer's disease

We investigated the utility of sulcal width measures in the diagnosis of Alzheimer's disease (AD). Sixty-six biologically confirmed AD patients (positive amyloid positron emission tomography [PET] and/or AD cerebrospinal fluid profile) were contrasted to 35 controls with negative amyloid PET. Patients were classified into prodromal or dementia stages as well as into late onset (LOAD, n = 31) or early onset (EOAD, n = 35) subgroups according to their age of onset. An automated method was used to calculate sulcal widths and hippocampal volumes (HV). In EOAD, the greatest ability to differentiate patients from age-matched controls, regardless of severity, was displayed by sulcal width of the temporoparietal cortex. In this region, diagnosis accuracy was better than the HV, especially at prodromal stage. In LOAD, HV provided the best discrimination power from age-matched controls. In conclusion, sulcal width measures are better markers than the HV for identifying prodromal AD in patients aged <65 years. In contrast, in older patients, the risk of over-diagnosis from using only sulcal enlargement is important.

[1]  Tao Liu,et al.  Limited relationships between two-year changes in sulcal morphology and other common neuroimaging indices in the elderly , 2013, NeuroImage.

[2]  Christian Böhm,et al.  Automated detection of brain atrophy patterns based on MRI for the prediction of Alzheimer's disease , 2010, NeuroImage.

[3]  D. Louis Collins,et al.  Brain morphometry using 3D moment invariants , 2004, Medical Image Anal..

[4]  Magda Tsolaki,et al.  AddNeuroMed and ADNI: Similar patterns of Alzheimer's atrophy and automated MRI classification accuracy in Europe and North America , 2011, NeuroImage.

[5]  Arnaud Cachia,et al.  In-vivo measurement of cortical morphology: means and meanings. , 2010, Current opinion in neurology.

[6]  Olivier Colliot,et al.  Similar amyloid-β burden in posterior cortical atrophy and Alzheimer's disease. , 2011, Brain : a journal of neurology.

[7]  Ronald C. Petersen,et al.  Revision of the criteria for Alzheimer's disease: A symposium , 2011, Alzheimer's & Dementia.

[8]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.

[9]  Nick C Fox,et al.  Visual assessment of atrophy on magnetic resonance imaging in the diagnosis of pathologically confirmed young-onset dementias. , 2005, Archives of neurology.

[10]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[11]  Olivier Colliot,et al.  Is hippocampal volume a good marker to differentiate Alzheimer's disease from frontotemporal dementia? , 2013, Alzheimer's & Dementia.

[12]  F. Castellanos,et al.  An 1H-MRS framework predicts the onset of Alzheimer's disease symptoms in PSEN1 mutation carriers , 2014, Alzheimer's & Dementia.

[13]  Olivier Colliot,et al.  The amnestic syndrome of hippocampal type in Alzheimer's disease: an MRI study. , 2010, Journal of Alzheimer's disease : JAD.

[14]  J. Morris,et al.  The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[15]  G. Frisoni,et al.  Hippocampal and entorhinal cortex atrophy in frontotemporal dementia and Alzheimer’s disease , 1999, Neurology.

[16]  Sébastien Ourselin,et al.  Cortical Folding Analysis on Patients with Alzheimer's Disease and Mild Cognitive Impairment , 2012, MICCAI.

[17]  Magda Tsolaki,et al.  Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study , 2009, The Lancet Neurology.

[18]  M. Åsberg,et al.  A New Depression Scale Designed to be Sensitive to Change , 1979, British Journal of Psychiatry.

[19]  Kiralee M. Hayashi,et al.  The topography of grey matter involvement in early and late onset Alzheimer's disease. , 2007, Brain : a journal of neurology.

[20]  Lutz Jäncke,et al.  Volumes of lateral temporal and parietal structures distinguish between healthy aging, mild cognitive impairment, and Alzheimer's disease. , 2011, Journal of Alzheimer's disease : JAD.

[21]  Jong-Min Lee,et al.  Automated Sulcal Depth Measurement on Cortical Surface Reflecting Geometrical Properties of Sulci , 2013, PloS one.

[22]  Sang Won Seo,et al.  Sulcal morphology changes and their relationship with cortical thickness and gyral white matter volume in mild cognitive impairment and Alzheimer's disease , 2008, NeuroImage.

[23]  H. Benali,et al.  Fully automatic hippocampus segmentation and classification in Alzheimer's disease and mild cognitive impairment applied on data from ADNI , 2009, Hippocampus.

[24]  Lei Wang,et al.  Integrated cortical structural marker for Alzheimer's disease , 2015, Neurobiology of Aging.

[25]  E. Duchesnay,et al.  A framework to study the cortical folding patterns , 2004, NeuroImage.

[26]  Alexander Hammers,et al.  Automatic segmentation of the hippocampus and the amygdala driven by hybrid constraints: Method and validation , 2009, NeuroImage.

[27]  Jesse S. Jin,et al.  Cortical Gyrification and Sulcal Spans in Early Stage Alzheimer's Disease , 2012, PloS one.

[28]  Jean-Francois Mangin,et al.  Cortical sulci recognition and spatial normalization , 2011, Medical Image Anal..

[29]  J. Morris The Clinical Dementia Rating (CDR) , 1993, Neurology.

[30]  Nick C Fox,et al.  Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria , 2014, The Lancet Neurology.

[31]  Tao Liu,et al.  The effects of age and sex on cortical sulci in the elderly , 2010, NeuroImage.

[32]  M. Ceccaldi,et al.  Utilisation des biomarqueurs du LCR dans le diagnostic de la maladie d’Alzheimer en pratique clinique , 2011 .

[33]  Jong-Min Lee,et al.  Dimensionality reduced cortical features and their use in predicting longitudinal changes in Alzheimer's disease , 2013, Neuroscience Letters.

[34]  C. Jack,et al.  Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia , 2002, Neurology.

[35]  Tao Liu,et al.  Longitudinal changes in sulcal morphology associated with late-life aging and MCI , 2013, NeuroImage.

[36]  Sang Won Seo,et al.  Longitudinal changes of cortical thickness in early- versus late-onset Alzheimer's disease , 2013, Neurobiology of Aging.

[37]  S Lehéricy,et al.  VBM anticipates the rate of progression of Alzheimer disease , 2008, Neurology.

[38]  Marie Chupin,et al.  Automatic classi fi cation of patients with Alzheimer ' s disease from structural MRI : A comparison of ten methods using the ADNI database , 2010 .

[39]  C. Jack,et al.  Alzheimer's Disease Neuroimaging Initiative , 2008 .

[40]  M. Sarazin,et al.  Cerebrospinal fluid biomarkers in the differential diagnosis of Alzheimer's disease from other cortical dementias , 2010, Journal of Neurology, Neurosurgery & Psychiatry.

[41]  Nick C Fox,et al.  The clinical use of structural MRI in Alzheimer disease , 2010, Nature Reviews Neurology.

[42]  B. Dubois,et al.  Amnestic syndrome of the medial temporal type identifies prodromal AD , 2007, Neurology.

[43]  M. Weiner,et al.  Increased metabolic vulnerability in early-onset Alzheimer's disease is not related to amyloid burden. , 2010, Brain : a journal of neurology.

[44]  Rémi Cuingnet,et al.  Sulcal span in Azheimer's disease, amnestic mild cognitive impairment, and healthy controls. , 2012, Journal of Alzheimer's disease : JAD.